Maternal Cesarian Section Infection (MACSI) in Sierra Leone
MACSI
1 other identifier
observational
1,000
1 country
1
Brief Summary
Up to 1 in 5 women in Africa who deliver their baby by cesarean section get a wound infection. Surgical site infections (SSIs) are largely preventable, but they represent a considerable burden for health-care systems, particularly in low-income and middle-income countries. The prevention of these infections is complex and requires the integration of a range of preventive measures before, during, and after surgery. The aim of the proposed project is to determine the risk factors of Surgical Site Infection post-Cesarean Section in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. Secondary aims are to determine the incidence of SSI and the predictors of a negative outcome in women with post-CS SSI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
April 24, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedApril 30, 2019
April 1, 2019
1.4 years
April 24, 2019
April 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence
To determine the incidence of SSI after CS at PCMH during the study period
From hospital admission to hospital discharge, an overage of 1 month
Secondary Outcomes (3)
Prevalence of Main Features
From hospital admission to hospital discharge, an overage of 1 month
Prevalence of Negative Outcome
From hospital admission to hospital discharge, an overage of 1 month
Screening of Risk factors
From hospital admission to hospital discharge, an overage of 1 month
Study Arms (2)
Case
All women admitted or already hospitalized with suspected or confirmed infection after C/S will be screened for inclusion in the study as a case. Case confirmation will be clinically established by an infectious disease expert.SSI post C/S will be classified as: * Superficial incisional surgical site infection, * Deep incisional surgical site infection, * Organ/space surgical site infection.
Control
For each case, 3 patients undergoing the C/S on the same day and admitted to the same ward but not presenting Surgical Site Infection
Interventions
Eligibility Criteria
Pregnant women undergoing a C/S in an urban tertiary referral maternity hospital PCMH, Freetown (population served: 1'500'000; n. of total deliveries in 2017: 6'861; number of C/S in 2017: 2'028 ).
You may qualify if:
- All pregnant women undergoing a C/S in on the hospitals during the study period will be eligible to participate in this study.
You may not qualify if:
- The following conditions will not be considered as outcome, unless they present with systemic repercussion due to infection. For example:
- Vaginosis, candidiasis
- Lower tract urinary infection
- Fungal infections of the skin (athlete's foot, jockitch, ringworm, and yeast infections)
- Otitis
- Pharyngitis
- Herpes simplex, Herpes Zoster (Shingles)
- Uncomplicated chronic infection
- Sexually transmitted infections (Gonorrhoea, Syphilis, Trichomonas, Chlamydia, Hepatitis, HIV)
- Tuberculosis
- Bacterial colonization (presence of microorganisms without clinical signs/symptoms)
- Known vaginal, urethral and/or rectal GBS colonization
- Asymptomatic bacteriuria
- Known oropharyngeal colonization
- Non-infectious hypothermia/hyperthermia (e.g. related to epidural, thyroid storm, prostaglandin administration) during hospital stay
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Doctors with Africa - CUAMMlead
- University of Baricollaborator
- University of Palermocollaborator
Study Sites (1)
Princess Christian Maternity Hospital
Freetown, Sierra Leone
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giovanni Putoto, PhD
Department of operational research Doctors with Africa CUAMM Padova, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2019
First Posted
April 29, 2019
Study Start
May 1, 2018
Primary Completion
October 1, 2019
Study Completion
May 1, 2020
Last Updated
April 30, 2019
Record last verified: 2019-04